amphastar.com - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi AMPH
Investments in complex biosimilar systems and innovative drug delivery are driving growth for Amphastar Pharmaceuticals (AMPH). The annual EBITDA figure on the GURU.Markets terminal chart confirms this potential, stabilizing at 206.49. Revenues are based on the sale of generics and emergency medical supplies. Stable demand for injectable drugs shields the company from economic cyclicality, ensuring the resilience of its financial results.
Amphastar Pharmaceuticals, Inc. (AMPH) - rincian metrik lan laporan keuangan
- nilai pasar lan prakiraan target analis:
- rincian nilai pasar emiten:
- statistik nilai buku emiten:
- rincian struktur utang lan likuiditas bisnis:
Rasio Kabeh Utang marang Dana Pribadi Amphastar Pharmaceuticals|AMPH - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Amphastar Pharmaceuticals Inc|AMPH - Utang perusahaan|Utang marang nilai buku Amphastar Pharmaceuticals|AMPH - Utang jangka dawa perusahaan|Kewajiban jangka cendhak Amphastar Pharmaceuticals|Rasio jangkoan perantara amphastar.com
- statistik bathi lan rasio pasar:
AMPH - Bathi resik|Proyeksi bathi mangsa ngarep Amphastar Pharmaceuticals|AMPH - Rasio rega marang bathi|Kapitalisasi marang proyeksi bathi amphastar.com|AMPH - Pangali rega marang bathi tumrap wutah|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan Amphastar Pharmaceuticals|AMPH - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Amphastar Pharmaceuticals|AMPH - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan amphastar.com|AMPH - Wutah bathi resik saben saham ing taun iki|Dinamika bathi saben saham sing diarepake ing taun ngarep Amphastar Pharmaceuticals
Analisis kabeh metrik perusahaan:AMPH - Amphastar Corp
This indicator reflects the actual liquidity inflow from core operations, adjusted for the impact of taxes and debt obligations. By analyzing the consolidated EBITDA, an investor sees the actual speed of cash generation in a real-time assessment. The metric measures the efficiency of the operating cycle, excluding accounting distortions from depreciation. For Amphastar Pharmaceuticals (AMPH), this is critical during the transition from selling generics to implementing proprietary patented delivery systems. Steady growth in this line confirms the successful diversification of the business model.
Pesaing Amphastar Pharmaceuticals (AMPH)
Haleon Corp (HLN) - Bathi sadurunge bunga, pajak, lan amortisasi|KVUE: Bathi operasional sadurunge ngurangi amortisasi|veronapharma.com - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|MENS: Bathi operasional EBITDA|Ligand Pharmaceuticals Incorporated - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|AMRX (Amneal Pharmaceuticals Inc) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Perrigo Corp PRGO|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Alvotech (ALVO)|LQDA (liquidia.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA GLPG (Galapagos)|Bathi operasional EBITDA ANI Pharmaceuticals Inc ANIP|MNKD - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pacira Corp (PCRX) - Bathi operasional sadurunge ngurangi amortisasi|ARS Pharmaceuticals (SPRY) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi TBPH (theravance.com)|AQST (Aquestive Therapeutics, Inc.) - Bathi operasional EBITDA|SCPH: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA TECX|Bathi operasional EBITDA Tonix Pharmaceuticals Holding (TNXP)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi China SXT Pharmaceuticals, Inc. SXTC|Pendapatan operasional sadurunge ngurangi amortisasi Eupraxia Pharmaceuticals, Inc. (EPRX)|BHST: Bathi operasional sadurunge ngurangi amortisasi|Invizyne Technologies - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|ORMP: Bathi operasional EBITDA|Entera Bio (ENTX) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi MindWalk Holdings|ABVC: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional sadurunge ngurangi amortisasi CPIX (Cumberland Pharmaceuticals Inc.)|QNTM (Quantum BioPharma Ltd.) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi FibroGen Corp FGEN|TELO (Telomir Pharmaceuticals Corp) - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Rani Therapeutics Inc - Bathi operasional EBITDA|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi SNYR (Synergy CHC Corp)|RLYB: Bathi operasional EBITDA|Lexaria Bioscience Corp. (LEXX) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Pulmatrix Corp|PTHL: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Aptorum Group Limited (APM)|Bathi operasional sadurunge ngurangi amortisasi lyratherapeutics.com LYRA|Bathi operasional EBITDA IBO (Impact BioMedical)|Bathi operasional EBITDA TNF Pharmaceuticals Inc. TNFA|cbdMD Corp - Bathi operasional EBITDA|PainReform Corp (PRFX) - Bathi operasional sadurunge ngurangi amortisasi|CYTO: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi lipella.com (LIPO)|Bathi operasional sadurunge ngurangi amortisasi OPTN|Bathi operasional EBITDA Pieris Pharmaceuticals Inc|Bathi operasional sadurunge ngurangi amortisasi PROC (Procaps Group SA)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi PTPI|Bathi operasional EBITDA QLI (Qilian International)|Pendapatan operasional sadurunge ngurangi amortisasi acelyrin.com (SLRN)|TFF Pharmaceuticals, Inc. - Bathi operasional EBITDA
